RPIDNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31

RAPID MICRO BIOSYSTEMS, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026

$0.77+0.01 (+1.20%)

Close on Oct 19, 2026

Market cap: $37.40M
P/E (TTM): –
Dividend yield: –

RAPID MICRO BIOSYSTEMS, INC. balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31
Cash & Equivalents	20	17	25	27	179	30	13
Short-Term Investments	18	34	68	82	15	15	–
Cash & Short-Term Investments	38	51	92	109	194	45	13
Receivables	3.13	7.52	5.53	5.37	5.01	4.99	–
Inventory	18	20	20	21	16	8.97	–
Prepaid Expenses & Other	2.15	2.47	2.87	3.37	3.95	3.12	–
Other Current Assets	0.73	0.84	0.58	0.71	0.44	0.55	–
Total Current Assets	61	81	120	139	218	62	–
Property, Plant & Equipment	8.97	11	13	14	11	7.05	–
Gross Property, Plant & Equipment	28	28	27	26	23	17	–
Accumulated Depreciation	-19	-17	-14	-12	-12	-10	–
Long-Term Investments	–	0	2.91	30	9.97	–	–
Operating Lease Right-of-Use Assets	3.98	5.00	5.97	6.75	–	–	–
Other Long-Term Assets	0.32	0.53	0.77	1.12	1.49	0.70	–
Total Assets	75	98	143	191	241	70	–
Accounts Payable	4.14	2.54	1.97	5.43	3.94	4.47	–
Accrued Expenses	8.32	7.22	9.91	8.15	11	6.65	–
Current Portion of Leases	1.25	1.17	1.09	0.73	–	–	–
Current Income Taxes Payable	0.27	0.24	0.25	0.33	0.78	0.69	–
Deferred Revenue (Current)	4.73	6.60	5.97	4.71	3.31	4.42	–
Other Current Liabilities	–	–	–	–	0.34	0.11	–
Total Current Liabilities	18	18	19	19	18	16	–
Long-Term Debt	19	0	–	–	–	25	–
Long-Term Leases	3.54	4.78	5.95	6.90	–	–	–
Operating Lease Liabilities	4.79	5.95	7.04	7.63	–	–	–
Other Long-Term Liabilities	0.40	0.30	0.26	0.23	1.21	–	–
Total Liabilities	42	23	25	26	20	45	–
Total Debt	19	0	–	–	–	25	–
Preferred Stock	0	0	0	0	0	–	–
Additional Paid-In Capital	555	550	546	541	536	115	–
Retained Earnings	-522	-475	-428	-376	-315	-242	–
Comprehensive Income & Other	0.01	0.04	-0.10	-1.11	-0.02	0.00	–
Shareholders' Equity	33	75	118	164	221	-127	-83
Total Equity	33	75	118	164	221	-127	-83
Total Liabilities & Equity	75	98	143	191	241	70	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: –
Operating margin: -141.5%
Net margin: -145.6%
Return on equity, FY2025: -86.8%

Financial strength

Current ratio: 2.55
Debt to equity: 1.08
Debt to assets: 32.7%
Cash to current liabilities: 80.9%

Valuation

P/E ratio: –
Price to sales: 1.06
Price to book: 2.11
Dividend yield: –